New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws-Reference-Cited by-同舟云学术

New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws

Published:2020-07 Issue: Volume:106 Page:104659
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Bennardo Francesco,Buffone Caterina,Giudice Amerigo^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference13 articles.

1. Pathological findings of COVID-19 associated with acute respiratory distress syndrome;Xu;Lancet Respir Med,2020

2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges;Lai;Int J Antimicrob Agents,2020

3. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic.

4. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Yang;Lancet Respir Med,2020

5. Reducing mortality from 2019-nCoV: host-directed therapies should be an option;Zumla;The Lancet,2020

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteonecrosis of the Jaws Associated with Herpes Zoster Infection: A Systematic Review and a Rare Case Report;Microorganisms;2024-07-23

2. The effect of levilimab on the clinical presentations and changes in inflammatory biomarkers in outpatients with mild to moderate COVID-19;Meditsinskiy sovet = Medical Council;2024-06-06

3. Idiopathic avascular maxillary necrosis: A case report;Oral and Maxillofacial Surgery Cases;2023-12

4. Repurposed Drugs/Potential Pharmacological Agents Targeting Cytokine Release and Induction of Coagulation in COVID-19;Drug Repurposing Against SARS-CoV-2;2023-04-12

5. Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation;Bioinformatics and Biology Insights;2023-01